Nynikka R. Palmer

Nynikka R. Palmer

Auto-generated profile, based on publicly available information

Nynikka R. Palmer

Division of General Internal Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2011 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
ANAanand Dinkar Naik
Aanand Dinkar Naik
NPNynikka Palmer
Nynikka Palmer
NPNancy J. Petersen
Nancy J. Petersen
RSRichard L. Street
Richard L. Street
RRRadha Rao
Radha Rao
PHPaul Haidet
Paul Haidet
Diabetes mellitus (DM) is a serious and growing public health problem.1 The prevalence and morbidity of DM are greater among older adults who often have multiple chronic morbidities.2,3 Self-management skills are an essential means of reducing morbidity and health services use among older, comorbid patients with DM.4,5 However, delivery of effective self-management education and support can be difficult in traditional primary care, even among patients who have access to care, medications, and DM educators but who also have persistently uncontrolled DM.6 Many primary care clinics have few personnel trained to effectively deliver self-management education and support for chronic DM care. Furthermore, DM self-management is often poorly integrated with the physician-patient encounter, and evidence-linking self-management activities and health outcomes are often indirect at best.5,7

16 May 2013 in Cancer Causes & Control
Verified
Journal Article
Closed access
PDF file
KWKathryn E. Weaver
Kathryn E. Weaver
NPNynikka Palmer
Nynikka Palmer
LLLingyi Lu
Lingyi Lu
LCL. Douglas Case
L. Douglas Case
AGAnn M. Geiger
Ann M. Geiger

20 December 2014 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
NPNynikka R.A. Palmer
Nynikka R.A. Palmer
EKErin E. Kent
Erin E. Kent
LFLaura P. Forsythe
Laura P. Forsythe
NANeeraj K. Arora
Neeraj K. Arora
JRJulia H. Rowland
Julia H. Rowland
KWKathryn E. Weaver
Kathryn E. Weaver
Purpose: We examined racial and ethnic disparities in patient-provider communication (PPC), perceived care quality, and patient activation among long-term cancer survivors. Methods: In 2005 to 2006, survivors of breast, prostate, colorectal, ovarian, and endometrial cancers completed a mailed survey on cancer follow-up care. African American, Asian/Pacific Islander (Asian), Hispanic, and non-Hispanic white (white) survivors who had seen a physician for follow-up care in the past 2 years (n = 1,196) composed the analytic sample. We conducted linear and logistic regression analyses to identify racial and ethnic differences in PPC (overall communication and medical test communication), perceived care quality, and patient activation in clinical care (self-efficacy in medical decisions and perceived control). We further examined the potential contribution of PPC to racial and ethnic differences in perceived care quality and patient activation. Results: Compared with white survivors (mean score, 85.16), Hispanic (mean score, 79.95) and Asian (mean score, 76.55) survivors reported poorer overall communication (P = .04 and P < .001, respectively), and Asian survivors (mean score, 79.97) reported poorer medical test communication (P = .001). Asian survivors were less likely to report high care quality (odds ratio, 0.47; 95% CI, 0.30 to 0.72) and reported lower self-efficacy in medical decisions (mean score, 74.71; P < .001) compared with white survivors (mean score, 84.22). No disparity was found in perceived control. PPC was positively associated with care quality (P < .001) and self-efficacy (P < .001). After adjusting for PPC and other covariates, when compared with whites, Asian disparities remained significant. Conclusion: Asian survivors report poorer follow-up care communication and care quality. More research is needed to identify contributing factors beyond PPC, such as cultural influences and medical system factors.

1 October 2013 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
PDF file
NPNynikka R.A. Palmer
Nynikka R.A. Palmer
AGAnn M. Geiger
Ann M. Geiger
LLLingyi Lu
Lingyi Lu
LCL. Douglas Case
L. Douglas Case
KWKathryn E. Weaver
Kathryn E. Weaver
Background: Routine follow-up care is recommended to promote the well-being of cancer survivors, but financial difficulties may interfere. Rural–urban disparities in forgoing healthcare due to cost have been observed in the general population; however, it is unknown whether this disparity persists among survivors. The purpose of this study was to examine rural–urban disparities in forgoing healthcare after cancer due to cost. Methods: We analyzed data from 7,804 cancer survivors in the 2006 to 2010 National Health Interview Survey. Logistic regression models, adjusting for sociodemographic and clinical characteristics, were used to assess rural–urban disparities in forgoing medical care, prescription medications, and dental care due to cost, stratified by age (younger: 18–64, older: 65+). Results: Compared with urban survivors, younger rural survivors were more likely to forgo medical care (P < 0.001) and prescription medications (P < 0.001) due to cost; older rural survivors were more likely to forgo medical (P < 0.001) and dental care (P = 0.05). Rural–urban disparities did not persist among younger survivors in adjusted analyses; however, older rural survivors remained more likely to forgo medical [OR = 1.66, 95% confidence interval (CI) = 1.11–2.48] and dental care (OR = 1.54, 95%CI = 1.08–2.20). Conclusions: Adjustment for health insurance and other sociodemographic characteristics attenuates rural–urban disparities in forgoing healthcare among younger survivors, but not older survivors. Financial factors relating to healthcare use among rural survivors should be a topic of continued investigation. Impact: Addressing out-of-pocket costs may be an important step in reducing rural–urban disparities in healthcare, especially for older survivors. It will be important to monitor how healthcare reform efforts impact disparities observed in this vulnerable population. Cancer Epidemiol Biomarkers Prev; 22(10); 1668–76. ©2013 AACR.

29 March 2015 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
NPNynikka R. A. Palmer
Nynikka R. A. Palmer
KWKathryn E. Weaver
Kathryn E. Weaver
SHSally P. Hauser
Sally P. Hauser
JLJulia A. Lawrence
Julia A. Lawrence
JTJennifer Talton
Jennifer Talton
AGAnn M. Geiger
Ann M. Geiger

1 February 2011 in Journal Of Health Care For The Poor and Underserved
Verified
Journal Article
Closed access
PDF file
TFTisha M. Felder
Tisha M. Felder
NPNynikka R. Palmer
Nynikka R. Palmer
LLLincy S. Lal
Lincy S. Lal
PMPatricia Dolan Mullen
Patricia Dolan Mullen
Pharmaceutical patient assistance programs (PAPs) have the potential to improve prescription drug accessibility for eligible patients, but currently there is limited information regarding their effectiveness. In an attempt to provide a systematic description of primary studies on PAPs, we reviewed 33 unique studies from commercial and grey literature (e.g., government publications, conference abstracts) sources: 15 health care outcome evaluations, seven economic evaluations, seven surveys and four miscellaneous studies. Enrollment assistance for PAPs with additional medication services (e.g., counseling) was significantly associated with improved glycemic (standardized mean difference = −0.40, 95% CI = −0.59,−0.20; k = 3 one-group, pre-post-test; 1 comparison-group) and lipid (standardized mean difference = −0.52, 95% CI = 0.78,−0.27; k = 3 one-group, pre-post-test; 1 comparison group) control. Inadequately designed economic evaluations suggest free PAP medications offset health care institutions' costs for uncompensated medications and enrollment assistance programs. More rigorous research is needed to establish the clinical and cost-effectiveness of PAPs from a patient and health care institution perspective.